Given the implementation of the national Lynch syndrome registry in England and direct referral of individuals with Lynch syndrome into a well-established national bowel cancer screening programme in England, the management of individuals with a GPV in the MMR gene was not extensively discussed. This evidence concerns the gene MRC1 and intestinal cancer.